356 related articles for article (PubMed ID: 27622331)
1. T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
Marigo I; Zilio S; Desantis G; Mlecnik B; Agnellini AHR; Ugel S; Sasso MS; Qualls JE; Kratochvill F; Zanovello P; Molon B; Ries CH; Runza V; Hoves S; Bilocq AM; Bindea G; Mazza EMC; Bicciato S; Galon J; Murray PJ; Bronte V
Cancer Cell; 2016 Sep; 30(3):377-390. PubMed ID: 27622331
[TBL] [Abstract][Full Text] [Related]
2. CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.
Portillo JA; Feliciano LM; Okenka G; Heinzel F; Subauste MC; Subauste CS
Immunology; 2012 Feb; 135(2):140-50. PubMed ID: 22044243
[TBL] [Abstract][Full Text] [Related]
3. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.
Fujii S; Liu K; Smith C; Bonito AJ; Steinman RM
J Exp Med; 2004 Jun; 199(12):1607-18. PubMed ID: 15197224
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.
Nesbeth YC; Martinez DG; Toraya S; Scarlett UK; Cubillos-Ruiz JR; Rutkowski MR; Conejo-Garcia JR
J Immunol; 2010 May; 184(10):5654-62. PubMed ID: 20400704
[TBL] [Abstract][Full Text] [Related]
5. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
[TBL] [Abstract][Full Text] [Related]
6. IL-27 Negatively Regulates Tip-DC Development during Infection.
Liu G; Abas O; Fu Y; Chen Y; Strickland AB; Sun D; Shi M
mBio; 2021 Feb; 12(1):. PubMed ID: 33593983
[TBL] [Abstract][Full Text] [Related]
7. Functional dichotomy in CD40 reciprocally regulates effector T cell functions.
Murugaiyan G; Agrawal R; Mishra GC; Mitra D; Saha B
J Immunol; 2006 Nov; 177(10):6642-9. PubMed ID: 17082576
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
9. Generation and functional analysis of human TNF-α/iNOS-producing dendritic cells (Tip-DC).
Wilsmann-Theis D; Koch S; Mindnich C; Bonness S; Schnautz S; von Bubnoff D; Bieber T
Allergy; 2013 Jul; 68(7):890-8. PubMed ID: 23742057
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Kikuchi T; Miyazawa N; Moore MA; Crystal RG
Cancer Res; 2000 Nov; 60(22):6391-5. PubMed ID: 11103803
[TBL] [Abstract][Full Text] [Related]
13. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
15. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
Bachmann MF; Wong BR; Josien R; Steinman RM; Oxenius A; Choi Y
J Exp Med; 1999 Apr; 189(7):1025-31. PubMed ID: 10190893
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L.
Gao J; Luo SM; Peng ML; Deng T
J Cancer Res Clin Oncol; 2012 Jun; 138(6):917-26. PubMed ID: 22327301
[TBL] [Abstract][Full Text] [Related]
17. Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α.
Chang L; Zhang Z; Chen F; Zhang W; Song S; Song S
Med Oncol; 2017 Mar; 34(3):44. PubMed ID: 28194716
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
Kikuchi T; Moore MA; Crystal RG
Blood; 2000 Jul; 96(1):91-9. PubMed ID: 10891436
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
20. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells via increased dendritic cell maturation.
Parameswaran S; Khalil M; Ahmed KA; Sharma RK; Xiang J
Tumori; 2015; 101(6):637-43. PubMed ID: 25983089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
